These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6406591)

  • 41. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia.
    Sokol PA; Kooi C; Hodges RS; Cachia P; Woods DE
    J Infect Dis; 2000 May; 181(5):1682-92. PubMed ID: 10823769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three Pseudomonas aeruginosa strains with different protease profiles.
    Andrejko M; Zdybicka-Barabas A; Janczarek M; Cytryńska M
    Acta Biochim Pol; 2013; 60(1):83-90. PubMed ID: 23513190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse model.
    Cowell BA; Willcox MD; Hobden JA; Schneider RP; Tout S; Hazlett LD
    Exp Eye Res; 1998 Sep; 67(3):347-56. PubMed ID: 9778416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of clinical isolates of Pseudomonas aeruginosa. I. Resistance to serum bactericidal effect and production of proteolytic enzymes.
    Pajdak E; Szkarłat A; Kobylarz K
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):309-14. PubMed ID: 2129385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corneal ulcers caused by protease and elastase from Pseudomonas aeruginosa.
    Kawaharajo K; Abe C; Homma JY; Kawano M; Goto E
    Jpn J Exp Med; 1974 Oct; 44(5):435-42. PubMed ID: 4215914
    [No Abstract]   [Full Text] [Related]  

  • 48. Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas.
    Kessler E; Kennah HE; Brown SI
    Invest Ophthalmol Vis Sci; 1977 Jun; 16(6):488-97. PubMed ID: 405343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of elastase as a virulence factor in experimental Pseudomonas aeruginosa infection in mice.
    Tamura Y; Suzuki S; Sawada T
    Microb Pathog; 1992 Mar; 12(3):237-44. PubMed ID: 1614334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of immunization with multicomponent vaccines in protection against hemorrhagic pneumonia due to Pseudomonas aeruginosa infection in mink.
    Homma JY; Abe C; Yanagawa R; Noda H
    Rev Infect Dis; 1983; 5 Suppl 5():S858-66. PubMed ID: 6361961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of elastase from Pseudomonas aeruginosa with polymorphonuclear leukocytes and serum.
    Pajdak E; Pituch-Noworolska A; Stankiewicz D
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):499-505. PubMed ID: 3936453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida.
    Traidej M; Caballero AR; Marquart ME; Thibodeaux BA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):190-6. PubMed ID: 12506074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic approaches to study Pseudomonas aeruginosa protein antigens.
    Nicas TI; Iglewski BH
    Adv Exp Med Biol; 1985; 185():223-32. PubMed ID: 3000148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Peptidase activity and toxicity of strains of Pseudomonas aeruginosa].
    Pinna GG; Spano A; Carru C; Pes GM; Delogu G; Miscali AR; Zanetti S; Sisini A
    Boll Soc Ital Biol Sper; 1991 Mar; 67(3):287-94. PubMed ID: 1930904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Some biological and biochemical properties of toxins (extracellular proteolytic enzymes) of Pseudomonas aeruginosa strains.
    Muszyński Z; Kedzia WB
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(3):310-2. PubMed ID: 4213541
    [No Abstract]   [Full Text] [Related]  

  • 56. IgE antibody production to elastase toxoid of Pseudomonas aeruginosa in mice.
    Abe C; Homma JY
    Jpn J Exp Med; 1981 Feb; 51(1):71-3. PubMed ID: 6796729
    [No Abstract]   [Full Text] [Related]  

  • 57. New method of preparing elastase toxoid from Pseudomonas aeruginosa.
    Morihara K; Homma JY
    J Clin Microbiol; 1986 Jan; 23(1):53-5. PubMed ID: 3084545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental infections with protease-deficient mutants of Pseudomonas aeruginosa in mice.
    Wretlind B; Kronevi T
    J Med Microbiol; 1978 May; 11(2):145-54. PubMed ID: 96256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
    Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
    Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pleiotropic changes in the activities of extracellular toxins of Pseudomonas aeruginosa protease-deficient mutants.
    Aggarwal N; Kalra MS; Singh A
    Acta Microbiol Pol; 1989; 38(3-4):313-6. PubMed ID: 2484746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.